Close Menu
Dailyza | Tech, Investments, Business & World News
  • Startups
  • Venture Capital
  • World
  • Economy
  • Politics
  • Science
  • Technology
  • Travel
  • Culture
Facebook X (Twitter) Instagram
Trending
  • InsightFinder Secures Funding to Enhance AI IT Solutions
  • Dailyza: Anthropic’s AI Model Raises Concerns Over Safety Risks
  • STORM Therapeutics Secures $56M Funding for Groundbreaking Cancer Therapy
  • BioLamina Secures €20 Million Financing for Matrix Biology Innovation
  • Dailyza: UK Government Launches €573 Million Sovereign AI Initiative
  • X-energy Launches IPO Roadshow, Targets $814M for SMR Commercialization
  • Qalzy Launches Pre-Seed Round to Enhance AI Nutrition Scale
  • Upscale AI Secures $200M Series A to Enhance Data Centre Networking
Dailyza | Tech, Investments, Business & World NewsDailyza | Tech, Investments, Business & World News
Saturday, April 18
  • Startups
  • Venture Capital
  • World
  • Economy
  • Politics
  • Science
  • Technology
  • Travel
  • Culture
Dailyza | Tech, Investments, Business & World News
Home»Venture Capital
Evaro healthtech interface connecting NHS healthcare services into consumer mobile apps

Evaro raises $25M to plug NHS care into consumer apps

27 January 2026 Venture Capital No Comments2 Mins Read
Share
Facebook Twitter LinkedIn Pinterest Email

Evaro secures $25M to embed NHS care into everyday apps

UK healthtech startup Evaro has raised $25 million in fresh funding to bring NHS-grade healthcare services directly into the consumer apps people already use daily. The company’s platform is designed to let banking, retail, fitness and workplace apps offer seamless access to trusted clinical pathways without forcing users into separate healthcare portals.

A new layer between consumer apps and the NHS

Evaro positions itself as an infrastructure layer that connects familiar digital products with existing NHS services. Through secure APIs, partner apps can embed symptom checkers, triage tools, appointment booking and remote consultations, all underpinned by NHS clinical guidelines.

By meeting patients where they already are, Evaro aims to reduce friction in accessing care and to divert non-urgent cases away from overstretched primary care and emergency services. The company says its technology can be configured to support both NHS and private care pathways, giving partners flexibility while maintaining clinical safety standards.

Targeting pressure points in UK healthcare

The funding round comes as the UK grapples with long waiting lists, rising demand for urgent care and mounting pressure on GP practices. By integrating structured digital triage and signposting into consumer experiences, Evaro hopes to guide users to the right level of care earlier, reducing unnecessary appointments and call volumes.

The platform relies on a combination of clinical decision support and configurable care pathways, rather than fully autonomous AI algorithms, which allows healthcare providers to retain control over governance and risk. Partners can brand the experience as their own while Evaro manages interoperability, security and compliance.

Scaling partnerships across sectors

With the new capital, Evaro plans to expand its engineering, clinical and partnerships teams, deepen integrations with NHS systems and accelerate rollouts with consumer-facing brands. Priority sectors include digital banking, insurance, fitness platforms and large employers seeking to enhance employee wellbeing offerings.

For investors, the bet is that healthcare will increasingly be accessed through the everyday apps people trust, rather than standalone portals. If Evaro can become the default infrastructure for that shift in the UK, it could later replicate the model in other public health systems facing similar capacity challenges.

Previous ArticleEvaro raises €21M with Clue, Lovehoney to scale NHS health tech
Next Article GoCanopy secures €2.1M to build AI OS for real estate
Kenyon Shah
  • Website

Keep Reading

urfuture Secures £1.7M Seed Funding to Revolutionize Hiring

Dailyza: EU-Startups Summit 2026 to Ignite Innovation in Malta

Accel Secures $5 Billion to Fuel AI Startups Growth

Dailyza Announces EU-Startups Summit 2026 in Malta

Newfund Launches HEKA, Europe’s First €60M BrainTech Fund

GPO Fund’s Jeff Stewart on Strategic IPO Decisions for Startups

Add A Comment

Leave A Reply Cancel Reply

STORM Therapeutics Secures $56M Funding for Groundbreaking Cancer Therapy

Science 18 April 2026

STORM Therapeutics raises $56 million for Phase 2 trials of STC-15, the first METTL3 inhibitor targeting rare sarcoma cancers.

BioLamina Secures €20 Million Financing for Matrix Biology Innovation

urfuture Secures £1.7M Seed Funding to Revolutionize Hiring

CamGraPhIC Secures €211 Million Funding from European Commission

Dailyza: EU-Startups Summit 2026 to Ignite Innovation in Malta

Accel Secures $5 Billion to Fuel AI Startups Growth

EVANIUM Secures €2.2 Million to Advance OPTISOLV® Technology

Dailyza Announces EU-Startups Summit 2026 in Malta

Newfund Launches HEKA, Europe’s First €60M BrainTech Fund

GPO Fund’s Jeff Stewart on Strategic IPO Decisions for Startups

Dailyza Explores Compliance Challenges for Remote Startups in Europe

LightSeeds Secures €162k Funding to Boost CleanTech Solutions

Dailyza: Where Nordic Women-Founded Startups Face Capital Challenges

SiFive Secures $400M From NVIDIA, Apollo Ahead of IPO

EIGHT Portugal raises €3M Seed to scale video-first dating app

Dailyza | Tech, Investments, Business & World News
  • Startups
  • Contact
  • About Us
© 2026 Dailyza

Type above and press Enter to search. Press Esc to cancel.